These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2507817)

  • 1. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].
    Tsukamura M
    Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
    Tsukamura M
    Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of clinical efficacy of rifampicin in the treatment of nontuberculous mycobacteriosis from in vitro susceptibility testing].
    Tsukamura M
    Kekkaku; 1989 Jul; 64(7):453-8. PubMed ID: 2585946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
    Tsukamura M
    Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
    Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y
    Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
    Tsukamura M
    Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bactericidal activity of ofloxacin against Mycobacterium kansasii].
    Tsukamura M
    Kekkaku; 1990 Nov; 65(11):719-21. PubMed ID: 2277465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria].
    Yamane N; Onaga S; Saitoh H; Toyoshima S; Shimojima M; Kawahara S; Takashima T; Yamashita T
    Rinsho Byori; 2002 Apr; 50(4):381-91. PubMed ID: 12014018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug susceptibility test for Mycobacterium tuberculosis using non-radioactive substance, alpha-antigen].
    Shigeto E; Taska H
    Kekkaku; 1996 Mar; 71(3):245-52. PubMed ID: 8901226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bactericidal activity of antituberculosis drugs against Mycobacterium avium complex].
    Tsukamura M
    Kekkaku; 1990 Jan; 65(1):9-12. PubMed ID: 2313966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of mycobacteria growth indicator tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis isolates].
    Suzuki K; Tsuyuguchi K; Matsumoto H; Niimi A; Tanaka E; Murayama T; Amitani R; Kuze F
    Kekkaku; 1997 Apr; 72(4):187-92. PubMed ID: 9145648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
    Truffot-Pernot C; Giroir AM; Maury L; Grosset J
    Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
    Tsukamura M
    Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utility of the direct culture examination (Ziehl-Neelsen) using the Bactec system for the presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium xenopi, and Mycobacterium kansasii].
    Moreno C; Garrigó M; Sánchez F; Coll P
    Enferm Infecc Microbiol Clin; 1994 May; 12(5):241-5. PubMed ID: 7811323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cross-resistance relationships of antituberculosis drugs in Mycobacterium avium complex].
    Tsukamura M
    Kekkaku; 1989 Jan; 64(1):1-5. PubMed ID: 2709652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
    Young LS; Berlin OG; Inderlied CB
    Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.